News New Acute Treatment Option for Schizophrenia and Bipolar Disorder April 6, 2022 Read More » Ardelyx Launches Irritable Bowel Syndrome Treatment Ibsrela April 4, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in April April 1, 2022 Read More » Yescarta Granted Approval for Earlier Use in B-Cell Lymphoma April 1, 2022 Read More » Triumeq PD Approved to Treat HIV April 1, 2022 Read More » Edurant and Vocabria Now Approved for Pediatric Patients March 30, 2022 Read More » Cabenuva Approved for Children, No Longer Requires Lead-In Therapy March 30, 2022 Read More » Teva Recalls One Lot of Leukemia Medication March 29, 2022 Read More » Higher Ozempic Dose Available to Improve Blood Sugar Control March 29, 2022 Read More » Page1 … Page34 Page35 Page36 Page37 Page38 … Page41 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in April April 1, 2022 Read More »